- For Patients
- Introduction to the Marshall Protocol
- Length of the MP
- Immunopathology
- Managing immunopathology
- Food and drink
- Light restriction
- Vitamin D metabolite calculator - get feedback on vitamin D results
- Therapeutic probe - best method for determining MP suitability
- Starting the Marshall Protocol
- Resources for patients
- Marshall Protocol summary
- Palliative vs. curative treatments
- Patient interviews on Bacteriality
- Non-MP treatments
- Glossary
- The Protocol
- Marshall Protocol summary
- Publications and presentations
- Science behind immunopathology
- Science behind olmesartan (Benicar)
- Safety of olmesartan
- Resources for physicians
- Vitamin D metabolite calculator - get feedback on vitamin D results
- Therapeutic probe - best method for determining MP suitability
- Physicians' concerns about the MP
- Notice for emergency medical personnel
- The Pathogenesis
- Publications and presentations
- Science behind Marshall Pathogenesis
- Microbes in the human body
- Successive infection and variability in disease
- Autoimmune theory of disease
- Science behind vitamin D
- Metabolism of vitamin D and the VDR
- Th1 Spectrum Disorder - how chronic inflammatory diseases are related
- Transmission of bacteria and onset of chronic disease
- Evolutionary perspective on disease
- Incidence and prevalence of disease
- Evidence that chronic disease is caused by pathogens
- Diseases
- Foundation
- Related Sites
Differences
This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision | |||
|
home:pathogenesis:microbiota:biofilm [01.11.2019] sallieq [More research] |
home:pathogenesis:microbiota:biofilm [01.12.2020] (current) sallieq [More research] |
||
|---|---|---|---|
| Line 236: | Line 236: | ||
| A specific response to pH by isolates of Haemophilus influenzae (({{pubmed>long:24555828}})) | A specific response to pH by isolates of Haemophilus influenzae (({{pubmed>long:24555828}})) | ||
| - | Wound Biofilm: Current Perspectives and Strategies on Biofilm Disruption and Treatments (({{pubmed>long:28682297}})) | + | 2017 Wound Biofilm: Current Perspectives and Strategies on Biofilm Disruption and Treatments (({{pubmed>long:28682297}})) |
| - | Proteinase K treatment with antibiotics showed a synergistic effect against S. aureus biofilms. (({{pubmed>long:29205189}})) | + | 2017 Proteinase K treatment with antibiotics showed a synergistic effect against S. aureus biofilms. (({{pubmed>long:29205189}})) |
| + | |||
| + | The role of extracellular DNA in the maintenance of biofilms (({{pubmed>long:19064900}})) | ||
| + | |||
| + | Increased intestinal permeability as a direct effect of treatment with a bacteriophage cocktail (({{pubmed>long:27340433}})) | ||
| + | |||
| + | 2017 Novel insights into the role of bacteriophages as potentially pathogenic for mammals (({{pubmed>long:28765534}})) | ||
| ===== Read more ===== | ===== Read more ===== | ||
home/pathogenesis/microbiota/biofilm.1547179560.txt.gz · Last modified: 01.11.2019 by sallieq
© 2015, Autoimmunity Research Foundation. All Rights Reserved.